The Family Firm’s Protolabs PRLB Stock Holding History

The Family Firm’s Portfolio PRLB Stock Details PRLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-21	Closed	-$649	–	678
2024 Q2	$649	Buy	+21	New	+$666	﹤0.01%	849

Other funds holding PRLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

The Family Firm's PRLB Position: Q3 2024 in Review

The Family Firm sold out of Protolabs (PRLB) in Q3 2024, closing a stake of 21 shares — an estimated $649 sold.

The Family Firm first reported a position in PRLB in Q2 2024 and held it in 1 quarter. The position peaked at $649 in Q2 2024. 193 funds tracked by Wall St. Rank hold PRLB as of Q3 2024.

The Family Firm reported no remaining Protolabs position as of Q3 2024 after selling out during the quarter.
The Family Firm sold 21 Protolabs shares in Q3 2024, an estimated $649.
The Family Firm first reported a position in Protolabs in Q2 2024 and held it in 1 quarter.
The Family Firm's Protolabs position peaked at $649 in Q2 2024.
193 funds tracked by Wall St. Rank held Protolabs as of Q3 2024.

Based on The Family Firm's 13F filing for Q3 2024, filed 17 Oct 2024.